StockNews.AI
MYO
StockNews.AI
131 days

Myomo Announces Upcoming Changes to its Board of Directors

1. Directors Knapp and Jacobovitz will not seek re-election at Myomo. 2. Leadership changes may impact Myomo's strategic direction.

2m saved
Insight
Article

FAQ

Why Neutral?

Director changes can influence company strategy, but current projects remain steady.

How important is it?

While board changes can alter strategic focus, no immediate operational shifts are noted.

Why Short Term?

Immediate reactions from investors may occur, but long-term impact is uncertain.

Related Companies

MDGSOTN
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that directors Amy Knapp and Yitzchak Jacobovitz have informed the board they will not stand for re-election as Class II directors. Ms. Knapp has been a director since July 2016 and Mr. Jacobovitz has served on Myomo's board since January 2.

Related News